Biomarker analysis of patients with follicular lymphoma treated with ibrutinib in the phase 2 DAWN study.
Salles, G Gopal, A Schuster, S Trotman, J Hess, G Hou, JZ Yacoub, A Lill, M Martin, P Vitolo, U
Salles, G
Gopal, A
Schuster, S
Trotman, J
Hess, G
Hou, JZ
Yacoub, A
Lill, M
Martin, P
Vitolo, U
Citations
Altmetric:
Abstract
Description
Lymphoma Research Team
Date
2017
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Biomarker analysis of patients with follicular lymphoma treated with ibrutinib in the phase 2 DAWN study. 2017, 102(s2): 464 Haematologica